Alexion's Pipeline Rebuild Plan Targets Wilson's Liver Drug, More M&A Likely

 
• By Sten Stovall
  
Liver
Wilson's WTX101 promises to remove copper from the liver • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business